TechFlow news, September 23 — Scilex Holding Company, a publicly traded company on the U.S. stock market, disclosed that it has entered into a securities purchase agreement with an institutional investor to exchange ordinary shares of Semnur Pharmaceuticals, Inc. valued at $200 million for an equivalent amount of Bitcoin.
Under the terms of the agreement, Scilex Holding Company will swap its ordinary shares in Semnur Pharmaceuticals, valued at $200 million, with the institutional investor for an equivalent value in Bitcoin.
Add to Favorites
Share to Social Media
